Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1) an-label, 2 trial

DSpace Repository

Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1) an-label, 2 trial

Author: de Bono, Johann S.; Mehra, Niven; Scagliotti, Giorgio, V; Castro, Elena; Dorff, Tanya; Stirling, Adam; Stenzl, Arnulf; Fleming, Mark T.; Higano, Celestia S.; Saad, Fred; Buttigliero, Consuelo; van Oort, Inge M.; Laird, A. Douglas; Mata, Marielena; Chen, Hsiang-Chun; Healy, Cynthia G.; Czibere, Akos; Fizazi, Karim
Tübinger Autor(en):
Stenzl, Arnulf
Published in: Lancet Oncology (2021), Bd. 22, H. 9, S. 1250-1264
Verlagsangabe: Elsevier Science Inc
Language: English
Full text: http://dx.doi.org/10.1016/S1470-2045(21)00376-4
ISSN: 1474-5488
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)